ANNA MEHLER PAPERNY
Friday, March 04, 2011 – Globe and Mail
The wannabe lifesaving vaccines of the future are being test-driven on a treed campus in Toronto’s north end.
Here, in Sanofi Pasteur’s Canadian headquarters near Dufferin and Steeles, serums vaccines go from painstaking prototypes to mass-produced doses ready to be shipped worldwide. It’s a good time to be in the inoculation business – even for a site that’s been doing it for a century.
The vaccine giant’s made-in-Toronto breakthrough, a five-component shot protecting kids from whooping cough, has proven a billion-dollar international hit – so much so that the company is building a new $180-million manufacturing plant to keep up with exponentially growing demand.
But that’s just the beginning: Over the next 15 years, Sanofi Pasteur hopes to develop now largely fallow areas of its campus, land currently occupied primarily by trees and a couple of storage facilities.